BREAKWATER
1 February 2025
During the 2025 annual ASCO GI meeting, Prof Scott Kopetz shared the first results of the randomized phase III BREAKWATER trial. In this video, Prof Kopetz shares the key take-aways
MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world. In collaboration with Belgian and international experts, we bring the newest data in several different formats to Belgian physicians.
Congress reports
Coming up
Past congresses
What's New Doc?
Latest publications
CheckMate 8HW
30 January 2025
In this video, Prof Thierry André and Prof Em Eric Van Cutsem discuss the key take home messages from this presentation.
Colorectal Cancer
29 January 2025
In this video, Dr Gertjan Rasschaert, consultant GI oncology at the University Hospitals Leuven summarises the key take home messages from ASCO GI 2025 related to colorectal cancer (CRC).
CheckMate-649: 5-year follow up data
27 January 2025
In this video, Prof Em Eric Van Cutsem and Prof Yelena Janjigian discuss the 5-year follow-up data of this study as presented during ASCO GI 2025.
Pancreatic & Hepatobiliary cancer
27 January 2025
In this video, Prof Anne Demols, summarises the key take-aways from ASCO GI 2025 related to pancreatic and hepatobiliary cancer. While ASCO GI did not prove to be a ‘grand